TARGETING MASH: HOW INNOVATIVE DRUGS ARE SHAPING THE FUTURE

Targeting MASH: How Innovative Drugs Are Shaping the Future The Turning Point: How REZDIFFRA’s Approval is Reshaping MASH Treatment The approval of Rezdiffra marks a groundbreaking milestone in the treatment of metabolic-associated steatohepatitis (MASH), revolutionizing the therapeutic landscape. Unlike conventional approaches that emphasized